Abstract
Hypokalemic periodic paralysis (HypoPP) is an autosomal dominant disorder which is characterized by periodic attacks of muscle weakness associated with a decrease in the serum potassium level. The skeletal muscle calcium channel α-subunit gene CACNA1S is a major disease-causing gene for HypoPP, however, only three specific HypoPP-causing mutations, Arg528His, Arg1,239His and Arg1,239Gly, have been identified in CACNA1S to date. In this study, we studied a four-generation Chinese family with HypoPP with 43 living members and 19 affected individuals. Linkage analysis showed that the causative mutation in the family is linked to the CACNA1S gene with a LOD score of 6.7. DNA sequence analysis revealed a heterozygous C to G transition at nucleotide 1,582, resulting in a novel 1,582C→G (Arg528Gly) mutation. The Arg528Gly mutation co-segregated with all affected individuals in the family, and was not present in 200 matched normal controls. The penetrance of the Arg528Gly mutation was complete in male mutation carriers, however, a reduced penetrance of 83% (10/12) was observed in female carriers. No differences were detected for age-at-onset and severity of the disease (frequency of symptomatic attacks per year) between male and female patients. Oral intake of KCl is effective in blocking the symptomatic attacks. This study identifies a novel Arg528Gly mutation in the CACNA1S gene that causes HypoPP in a Chinese family, expands the spectrum of mutations causing HypoPP, and demonstrates a gender difference in the penetrance of the disease.
Similar content being viewed by others
Abbreviations
- CACNA1S :
-
Skeletal muscle voltage-gated calcium channel α-subunit
- HyperPP :
-
Hyperkalemic periodic paralysis
- HypoPP :
-
Hypokalemic periodic paralysis
- KCNE3 :
-
Voltage-gated potassium channel β subunit gene
- PCR :
-
Polymerase chain reaction
- RFLP :
-
Restriction fragment length polymorphism
- SCN4A :
-
Skeletal muscle voltage-gated sodium channel α-subunit
References
Lehmann-Horn F, Engel AG, Ricker K, Rüdel R (1994) The periodic paralyses and paramyotonia congenita. In: Engel AG, Franzini-Armstrong C (eds) Myology. McGraw-Hill, New York, pp 1304–1334
Kantola IM, Tarssanen LT (1992) Familial hypokalaemic periodic paralysis in Finland. J Neurol Neurosurg Psychiatry 55:322–324
Ptacek LJ, Tawil R, Griggs RC, Engel AG, Layzer RB, Kwiecinski H, McManis PG, Santiago L, Moore M, Fouad G (1994) Dihydropyridine receptor mutations cause hypokalemic periodic paralysis. Cell 77:863–868
Ptacek LJ, George AL Jr, Griggs RC, Tawil R, Kallen RG, Barchi RL, Robertson M, Leppert MF (1991) Identification of a mutation in the gene causing hyperkalemic periodic paralysis. Cell 67:1021–1027
Ptacek LJ, George AL Jr, Barchi RL, Griggs RC, Riggs JE, Robertson M, Leppert MF (1992) Mutations in an S4 segment of the adult skeletal muscle sodium channel cause paramyotonia congenita. Neuron 8:891–897
Abbott GW, Butler MH, Bendahhou S, Dalakas MC, Ptacek LJ, Goldstein SA (2001) MiRP2 forms potassium channels in skeletal muscle with Kv3.4 and is associated with periodic paralysis. Cell 104:217–231
Jurkat-Rott K, Lehmann-Horn F (2004) Periodic paralysis mutation MiRP2-R83H in controls: interpretations and general recommendation. Neurology 62:1012–1015
Sternberg D, Tabti N, Fournier E, Hainque B, Fontaine B (2003) Lack of association of the potassium channel-associated peptide MiRP2-R83H variant with periodic paralysis. Neurology 61:857–859
Hogan K, Gregg RG, Powers PA (1996) The structure of the gene encoding the human skeletal muscle alpha 1 subunit of the dihydropyridine-sensitive L-type calcium channel (CACNL1A3). Genomics 31:392–394
Caciotti A, Morrone A, Domenici R, Donati MA, Zammarchi E (2003) Severe prognosis in a large family with hypokalemic periodic paralysis. Muscle Nerve 27:165–169
Elbaz A, Vale-Santos J, Jurkat-Rott K, Lapie P, Ophoff RA, Bady B, Links TP, Piussan C, Vila A, Monnier N (1995) Hypokalemic periodic paralysis and the dihydropyridine receptor (CACNL1A3): genotype/phenotype correlations for two predominant mutations and evidence for the absence of a founder effect in 16 Caucasian families. Am J Hum Genet 56:374–380
Fouad G, Dalakas M, Servidei S, Mendell JR, Van den Bergh P, Angelini C, Alderson K, Griggs RC, Tawil R, Gregg R, Hogan K, Powers PA, Weinberg N, Malonee W, Ptacek LJ (1997) Genotype-phenotype correlations of DHP receptor alpha 1-subunit gene mutations causing hypokalemic periodic paralysis. Neuromuscul Disord 7:33–38
Grosson CL, Esteban J, Kenna-Yasek D, Gusella JF, Brown RH Jr (1996) Hypokalemic periodic paralysis mutations: confirmation of mutation and analysis of founder effect. Neuromuscul Disord 6:27–31
Ikeda Y, Watanabe M, Shoji M (1997) Mutation analysis of the CACNL1A3 gene in Japanese hypokalemic periodic paralysis families. Nippon Rinsho 55:3247–3252
Jurkat-Rott K, Lehmann-Horn F, Elbaz A, Heine R, Gregg RG, Hogan K, Powers PA, Lapie P, Vale-Santos JE, Weissenbach J (1994) A calcium channel mutation causing hypokalemic periodic paralysis. Hum Mol Genet 3:1415–1419
Kawamura S, Ikeda Y, Tomita K, Watanabe N, Seki K (2004) A family of hypokalemic periodic paralysis with CACNA1S gene mutation showing incomplete penetrance in women. Intern Med 43:218–222
Kim SH, Kim UK, Chae JJ, Kim DJ, Oh HY, Kim BJ, Lee CC (2001) Identification of mutations including de novo mutations in Korean patients with hypokalaemic periodic paralysis. Nephrol Dial Transplant 16:939–944
Kusumi M, Kumada H, Adachi Y, Nakashima K (2001) Muscle weakness in a Japanese family of Arg1239His mutation hypokalemic periodic paralysis. Psychiatry Clin Neurosci 55:539–541
Sillen A, Sorensen T, Kantola I, Friis ML, Gustavson KH, Wadelius C (1997) Identification of mutations in the CACNL1A3 gene in 13 families of Scandinavian origin having hypokalemic periodic paralysis and evidence of a founder effect in Danish families. Am J Med Genet 69:102–106
Stewart SL, Hogan K, Rosenberg H, Fletcher JE (2001) Identification of the Arg1086His mutation in the alpha subunit of the voltage-dependent calcium channel (CACNA1S) in a North American family with malignant hyperthermia. Clin Genet 59:178–184
Monnier N, Procaccio V, Stieglitz P, Lunardi J (1997) Malignant-hyperthermia susceptibility is associated with a mutation of the alpha 1-subunit of the human dihydropyridine-sensitive L-type voltage-dependent calcium-channel receptor in skeletal muscle. Am J Hum Genet 60:1316–1325
Wang L, Fan C, Topol SE, Topol EJ, Wang Q (2003) Mutation of MEF2A in an inherited disorder with features of coronary artery disease. Science 302:1578–1581
Wang Q, Shen J, Splawski I, Atkinson D, Li Z, Robinson JL, Moss AJ, Towbin JA, Keating MT (1995) SCN5A mutations associated with an inherited cardiac arrhythmia, long QT syndrome. Cell 80:805–811
Wang Q, Curran ME, Splawski I, Burn TC, Millholland JM, VanRaay TJ, Shen J, Timothy KW, Vincent GM, de Jager T, Schwartz PJ, Toubin JA, Moss AJ, Atkinson DL, Landes GM, Connors TD, Keating MT (1996) Positional cloning of a novel potassium channel gene: KVLQT1 mutations cause cardiac arrhythmias. Nat Genet 12:17–23
Morrill JA, Brown RH Jr, Cannon SC (1998) Gating of the L-type Ca channel in human skeletal myotubes: an activation defect caused by the hypokalemic periodic paralysis mutation R528H. J Neurosci 18:10320–10334
Morrill JA, Cannon SC (1999) Effects of mutations causing hypokalaemic periodic paralysis on the skeletal muscle L-type Ca2+ channel expressed in Xenopus laevis oocytes. J Physiol 520:321–336
Acknowledgements
We are grateful to the family members. This study would be impossible without their enthusiastic participation. This work was supported by two grants from the Chinese Ministry of Science and Technology National High Technology “863” Programs of China No. 2002BA711A07 (one to Q.W. and the other to J.Y.; Professor Yan Shen is the Chief Scientist on the overall project).
Author information
Authors and Affiliations
Corresponding authors
Additional information
Qiufen Wang and Mugen Liu contributed equally to this work
Rights and permissions
About this article
Cite this article
Wang, Q., Liu, M., Xu, C. et al. Novel CACNA1S mutation causes autosomal dominant hypokalemic periodic paralysis in a Chinese family. J Mol Med 83, 203–208 (2005). https://doi.org/10.1007/s00109-005-0638-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00109-005-0638-4